The Parasite and Infestation Study
Understanding the Experience of Patient-Physician Diagnostic Incongruency: I Know Something is Wrong But No One Believes Me
1 other identifier
observational
25
1 country
1
Brief Summary
Many people have evidence of bugs, parasites, and infestation, but are told by others that they cannot find a cause. This distressing and frustrating experience can last for years, as the person seeks answers. The current study aims to understand the experience of these individuals. In a 1-2 hour session over Zoom, the investigators will ask participants questions about their experience, have them complete self-report questionnaires, and ask them to complete a few games on the computer. The investigators' goal is to help characterize and understand individuals with this experience to aid in better treatment and inform recommendations for providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
September 30, 2026
September 1, 2026
4.9 years
September 18, 2026
September 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Psychological Wellbeing
Total score on the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS); scores range from 14-70; higher scores reflect greater wellbeing
Baseline
Social Network
Ludden Social Network Scale - total score; higher scores reflect larger and closer social network (score: 0-30)
Baseline
Depression
Total score - Beck Depression Inventory -II; Scores range from 0-63 with higher scores reflecting worse depression
Baseline
Anxiety
Perseverative Thinking Questionnaire (PTQ); scores range from 0-60, higher scores reflect more perseveration
Baseline
Belief Updating
Expectations of prior volatility (mu3) calculated from reversal learning task; higher parameter scores reflect greater expectations of volatility
Baseline
BADE
Evidence Integration Impairment (EII) will be calculated based on decisions on the Bias Against Disconfirmatory Evidence task. Higher scores reflect more difficulty integrating information
Baseline
Interoceptive Awareness
Multidimensional Assessment of Interoceptive Awareness-2; scores range from 0-185; higher scores reflect better interpersonal awareness
Baseline
Dissociation
Cernis Felt Sense of Anomaly Scale (CEFSA); scores range from 0-140, higher scores reflect more severe dissociative experiences
Baseline
Childhood Trauma
Childhood Trauma Questionnaire (CTQ)- scores range from 5-100, higher scores reflect more severe childhood maltreatment
Baseline
DACOBS
Davos Assessment of Cognitive Biases Scale; higher scores reflect more severe cognitive biases. Scores range from 42-294
Baseline
Study Arms (1)
PPDI Group
Interventions
Eligibility Criteria
Adults with a persistent experience of infestation or parasite that physicians or other professionals report no evidence for.
You may qualify if:
- Men and women aged 18-70 years old
- At least 50% certain that they have an active infection/infestation/parasite, despite being told by doctor that they do not
- Ability to read and speak English
- Access to a computer or phone for virtual visit
- No self-reported history of schizophrenia-spectrum disorder
You may not qualify if:
- Active substance use disorder (excluding nicotine and caffeine)
- History of severe head trauma
- Current use of antipsychotics
- Serious medical or neurological illness known to interfere with cognitive functioning
- Diagnosis of a learning disability or cognitive disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julia Sheffield, PhD
Vanderbilt University Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 30, 2026
Study Start
December 31, 2024
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
December 1, 2030
Last Updated
September 30, 2026
Record last verified: 2026-09